Home ETF List About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for NBIX

Stock NameNeurocrine Biosciences Inc
TickerNBIX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS64125C1099
LEI549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Sum Up The Parts: SCHG Could Be Worth $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:23:31
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,661 shares of the company’s stock after selling 663 shares during the quarter. Maryland […] - 2025-08-15 05:24:56
Charles Schwab Investment Management Inc. Purchases 13,216 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Charles Schwab Investment Management Inc. raised its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 775,773 shares of the company’s stock after acquiring an additional 13,216 shares during the quarter. Charles […] - 2025-08-13 05:10:46
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Blair William & Co. IL
Blair William & Co. IL cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 6,214 shares of the company’s stock after selling 242 shares during the period. Blair William & Co. IL’s holdings in Neurocrine Biosciences were worth $687,000 at the […] - 2025-08-11 05:52:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 72.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,441 shares of the company’s stock after selling 25,402 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-07 05:22:58
Natixis Advisors LLC Sells 292 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Natixis Advisors LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 33,312 shares of the company’s stock after selling 292 shares during the period. Natixis Advisors LLC’s holdings in Neurocrine Biosciences were worth $3,684,000 at the end of the […] - 2025-08-07 04:49:07
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo - 2025-08-05 01:16:10
Neurocrine (NBIX) Q2 Revenue Jumps 17%
Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96. - 2025-08-01 01:15:16
13,202 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,202 shares of the company’s stock, valued at approximately $1,460,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] - 2025-07-24 06:50:57
HighPoint Advisor Group LLC Purchases 366 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
HighPoint Advisor Group LLC boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 15.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,812 shares of the company’s stock after acquiring an additional 366 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Neurocrine Biosciences were worth $302,000 […] - 2025-07-24 05:51:14
Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at Truist Financial
Truist Financial initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $163.00 price target on the stock. NBIX has been the subject of several other reports. Royal Bank Of Canada reaffirmed an “outperform” rating and […] - 2025-07-22 04:28:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Cerity Partners LLC
Cerity Partners LLC decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 20.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,361 shares of the company’s stock after selling 8,376 shares during the quarter. Cerity Partners LLC’s holdings in […] - 2025-07-18 04:55:08
Ingrid Delaet Sells 457 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 457 shares of the business’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $135.00, for a total transaction of $61,695.00. Following the completion of the transaction, the insider directly owned 4,730 shares in the […] - 2025-07-14 07:16:47
Bank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Bank of New York Mellon Corp lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.8% during the first quarter, HoldingsChannel reports. The fund owned 828,682 shares of the company’s stock after selling 41,608 shares during the quarter. Bank of New York Mellon Corp’s holdings in Neurocrine Biosciences were worth $91,652,000 as […] - 2025-07-11 05:40:57
Principal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Principal Financial Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 248,420 shares of the company’s stock after selling 4,049 shares during the period. Principal Financial Group Inc. owned 0.25% of Neurocrine Biosciences […] - 2025-07-09 05:51:40
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of “Moderate Buy” by Analysts
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 […] - 2025-07-09 03:09:50
First Horizon Advisors Inc. Has $43,000 Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 55.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 385 shares of the company’s stock after selling 480 shares during the quarter. First Horizon Advisors […] - 2025-07-08 05:49:06
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Jude Onyia Sells 20,362 Shares
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Jude Onyia sold 20,362 shares of the company’s stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $130.13, for a total value of $2,649,707.06. Following the completion of the sale, the insider owned 18,289 shares of the company’s […] - 2025-07-08 05:06:50
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by KBC Group NV
KBC Group NV lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the 1st quarter, Holdings Channel reports. The fund owned 13,835 shares of the company’s stock after selling 495 shares during the period. KBC Group NV’s holdings in Neurocrine Biosciences were worth $1,530,000 as of its most recent filing […] - 2025-07-04 06:58:45
New York State Teachers Retirement System Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
New York State Teachers Retirement System lowered its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 108,481 shares of the company’s stock after selling 2,055 shares during the quarter. New York State Teachers Retirement System’s holdings in Neurocrine Biosciences were worth $11,998,000 […] - 2025-07-04 06:14:58
Amalgamated Bank Has $5.28 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Amalgamated Bank lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,719 shares of the company’s stock after selling 1,895 shares during the quarter. Amalgamated Bank’s holdings in Neurocrine Biosciences were […] - 2025-07-03 06:14:49
Sumitomo Mitsui Trust Group Inc. Sells 1,399 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 231,458 shares of the company’s stock after selling 1,399 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-07-03 05:35:01
Golden State Wealth Management LLC Grows Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Golden State Wealth Management LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 116.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397 shares of the company’s stock after purchasing an additional 214 shares during the quarter. […] - 2025-07-02 05:01:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 19,388 shares of the company’s stock after buying an additional 447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Neurocrine Biosciences were worth $2,144,000 as […] - 2025-06-27 05:10:49
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Retirement Systems of Alabama
Retirement Systems of Alabama cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.4% in the 1st quarter, Holdings Channel reports. The firm owned 121,352 shares of the company’s stock after selling 1,755 shares during the period. Retirement Systems of Alabama’s holdings in Neurocrine Biosciences were worth $13,422,000 at the […] - 2025-06-23 05:04:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by QRG Capital Management Inc.
QRG Capital Management Inc. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,062 shares of the company’s stock after buying an additional 1,330 shares […] - 2025-06-20 06:54:59
Sowell Financial Services LLC Takes Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sowell Financial Services LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,786 shares of the company’s stock, valued at approximately $529,000. Other institutional investors and hedge funds […] - 2025-06-20 05:29:06
Trust Point Inc. Sells 660 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Trust Point Inc. decreased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,823 shares of the company’s stock after selling 660 shares during the period. Trust Point Inc.’s holdings in […] - 2025-06-19 05:35:02
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Merit Financial Group LLC Acquires 345 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Merit Financial Group LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,153 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Merit Financial Group […] - 2025-06-11 05:00:51

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) NBIX holdings

DateNumber of NBIX Shares HeldBase Market Value of NBIX SharesLocal Market Value of NBIX SharesChange in NBIX Shares HeldChange in NBIX Base ValueCurrent Price per NBIX Share HeldPrevious Price per NBIX Share Held
2025-09-26 (Friday)16,170USD 2,296,140USD 2,296,140
2025-09-25 (Thursday)16,374NBIX holding increased by 110USD 2,306,933NBIX holding decreased by -78508USD 2,306,933110USD -78,508 USD 140.89 USD 146.67
2025-09-24 (Wednesday)16,264USD 2,385,441USD 2,385,441
2025-09-18 (Thursday)15,500NBIX holding increased by 56USD 2,257,730NBIX holding increased by 53408USD 2,257,73056USD 53,408 USD 145.66 USD 142.73
2025-09-17 (Wednesday)15,444NBIX holding increased by 86USD 2,204,322NBIX holding increased by 40380USD 2,204,32286USD 40,380 USD 142.73 USD 140.9
2025-09-16 (Tuesday)15,358USD 2,163,942NBIX holding increased by 7064USD 2,163,9420USD 7,064 USD 140.9 USD 140.44
2025-09-15 (Monday)15,358NBIX holding increased by 44USD 2,156,878NBIX holding decreased by -15719USD 2,156,87844USD -15,719 USD 140.44 USD 141.87
2025-09-12 (Friday)15,314NBIX holding increased by 34USD 2,172,597NBIX holding decreased by -21611USD 2,172,59734USD -21,611 USD 141.87 USD 143.6
2025-09-11 (Thursday)15,280NBIX holding decreased by -108USD 2,194,208NBIX holding increased by 20653USD 2,194,208-108USD 20,653 USD 143.6 USD 141.25
2025-09-10 (Wednesday)15,388NBIX holding increased by 20USD 2,173,555NBIX holding decreased by -42050USD 2,173,55520USD -42,050 USD 141.25 USD 144.17
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00BHZPJ890

Show aggregate share trades of NBIX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY110 140.890* 121.49
2025-09-18BUY56 145.660* 121.36
2025-09-17BUY86 142.730* 121.24
2025-09-15BUY44 140.440* 121.02
2025-09-12BUY34 141.870* 120.91
2025-09-11SELL-108 143.600* 120.78 Profit of 13,044 on sale
2025-09-10BUY20 141.250* 120.66
2025-09-09BUY26 144.170* 120.52
2025-08-27BUY16 138.130* 120.31
2025-08-21BUY4 135.280* 120.14
2025-08-19BUY12 132.810* 119.98
2025-07-21BUY2 131.830* 119.91
2025-07-18BUY94 132.020* 119.84
2025-07-17BUY12 134.110* 119.75
2025-07-16BUY186 133.480* 119.67
2025-07-15BUY110 131.240* 119.60
2025-07-03SELL-16 129.110* 119.48 Profit of 1,912 on sale
2025-07-02SELL-124 129.400* 119.42 Profit of 14,808 on sale
2025-06-30SELL-2 125.690* 119.38 Profit of 239 on sale
2025-06-27BUY8 125.420* 119.34
2025-06-26BUY4 126.710* 119.29
2025-06-25BUY8 127.780* 119.24
2025-06-24SELL-6 128.180* 119.18 Profit of 715 on sale
2025-06-17SELL-8 124.880* 118.94 Profit of 952 on sale
2025-06-13SELL-4 124.390* 118.87 Profit of 475 on sale
2025-06-12BUY6 125.010* 118.82
2025-06-06SELL-28 125.390* 118.65 Profit of 3,322 on sale
2025-06-05SELL-44 124.610* 118.61 Profit of 5,219 on sale
2025-06-04SELL-58 124.520* 118.57 Profit of 6,877 on sale
2025-06-03BUY12 125.000* 118.52
2025-06-02SELL-4 124.560* 118.48 Profit of 474 on sale
2025-05-30BUY22 123.020* 118.44
2025-05-29SELL-12 123.660* 118.41 Profit of 1,421 on sale
2025-05-28SELL-8 123.030* 118.37 Profit of 947 on sale
2025-05-23SELL-36 120.180* 118.31 Profit of 4,259 on sale
2025-05-22BUY2 119.120* 118.31
2025-05-21SELL-10 120.560* 118.29 Profit of 1,183 on sale
2025-05-20BUY44 122.960* 118.25
2025-05-16SELL-18 121.020* 118.20 Profit of 2,128 on sale
2025-05-15BUY2 120.270* 118.18
2025-05-14BUY36 118.780* 118.18
2025-05-13BUY134 116.870* 118.19
2025-05-12BUY106 120.430* 118.17
2025-05-09BUY34 115.710* 118.19
2025-05-08SELL-32 117.520* 118.19 Profit of 3,782 on sale
2025-05-07BUY94 121.610* 118.16
2025-05-06BUY22 118.920* 118.16
2025-05-02SELL-4 109.680* 118.30 Profit of 473 on sale
2025-05-01SELL-2 106.590* 118.40 Profit of 237 on sale
2025-04-28SELL-272 106.460* 118.70 Profit of 32,286 on sale
2025-04-25SELL-4 106.730* 118.80 Profit of 475 on sale
2025-04-24SELL-62 105.760* 118.92 Profit of 7,373 on sale
2025-04-23SELL-22 103.220* 119.06 Profit of 2,619 on sale
2025-04-22SELL-14 101.740* 119.22 Profit of 1,669 on sale
2025-04-16SELL-78 100.100* 119.91 Profit of 9,353 on sale
2025-04-11BUY38 90.870* 120.67
2025-04-10BUY12 90.720* 120.96
2025-04-09BUY20 95.280* 121.21
2025-04-08SELL-58 87.540* 121.55 Profit of 7,050 on sale
2025-04-07BUY38 93.250* 121.84
2025-04-04BUY86 95.650* 122.10
2025-04-02BUY34 108.310* 122.25
2025-04-01BUY16 107.000* 122.41
2025-03-31SELL-86 110.600* 122.53 Profit of 10,538 on sale
2025-03-28SELL-8 113.160* 122.63 Profit of 981 on sale
2025-03-26BUY2 114.450* 122.81
2025-03-25BUY6 116.180* 122.89
2025-03-24BUY12 115.600* 122.97
2025-03-21BUY308 111.920* 123.09
2025-03-20BUY4 110.070* 123.24
2025-03-19SELL-58 110.310* 123.39 Profit of 7,156 on sale
2025-03-17SELL-4 111.500* 123.69 Profit of 495 on sale
2025-03-14SELL-8 110.750* 123.84 Profit of 991 on sale
2025-03-13SELL-2 108.990* 124.02 Profit of 248 on sale
2025-03-12SELL-14 109.070* 124.20 Profit of 1,739 on sale
2025-03-11BUY2 107.220* 124.41
2025-03-06BUY124 112.660* 124.88
2025-03-05SELL-10 113.850* 125.03 Profit of 1,250 on sale
2025-03-03BUY6 114.480* 125.33
2025-02-28BUY42 118.720* 125.41
2025-02-27SELL-40 117.510* 125.52 Profit of 5,021 on sale
2025-02-26SELL-506 117.590* 125.63 Profit of 63,570 on sale
2025-02-25SELL-34 115.900* 125.77 Profit of 4,276 on sale
2025-02-24BUY50 119.110* 125.87
2025-02-21BUY26 120.690* 125.94
2025-02-20BUY6 116.110* 126.08
2025-02-19BUY4 114.260* 126.26
2025-02-18SELL-22 113.970* 126.45 Profit of 2,782 on sale
2025-02-14BUY6 115.020* 126.80
2025-02-13SELL-4 116.870* 126.96 Profit of 508 on sale
2025-02-12SELL-76 117.180* 127.12 Profit of 9,661 on sale
2025-02-06BUY10 150.510* 127.11
2025-02-05SELL-30 151.200* 126.69 Profit of 3,801 on sale
2025-02-03BUY4 150.100* 125.80
2025-01-30SELL-42 153.290* 124.79 Profit of 5,241 on sale
2025-01-28SELL-26 150.710* 123.77 Profit of 3,218 on sale
2025-01-27BUY12 148.190* 123.29
2025-01-24BUY22 148.730* 122.77
2025-01-23BUY22 147.580* 122.25
2024-12-09BUY4 129.120* 121.95
2024-12-06BUY62 128.140* 121.82
2024-12-04BUY46 127.740* 121.57
2024-12-03BUY26 125.440* 121.48
2024-12-02BUY60 125.890* 121.37
2024-11-29BUY6 126.750* 121.24
2024-11-27BUY2 126.590* 120.96
2024-11-26SELL-68 127.910* 120.77 Profit of 8,212 on sale
2024-11-25BUY12 127.110* 120.59
2024-11-22SELL-4 125.650* 120.45 Profit of 482 on sale
2024-11-21BUY84 125.000* 120.31
2024-11-19SELL-18 119.130* 120.26 Profit of 2,165 on sale
2024-11-18BUY38 117.620* 120.34
2024-11-12BUY2 127.010* 120.12
2024-11-08BUY6 125.740* 119.44
2024-11-08BUY6 125.740* 119.44
2024-11-07BUY154 123.980* 119.08
2024-11-07BUY154 123.980* 119.08
2024-11-06BUY4 125.300* 118.54
2024-11-06BUY4 125.300* 118.54
2024-11-05SELL-10 121.530* 118.25 Profit of 1,183 on sale
2024-11-05SELL-10 121.530* 118.25 Profit of 1,183 on sale
2024-11-04SELL-72 120.530* 118.01 Profit of 8,497 on sale
2024-11-04SELL-72 120.530* 118.01 Profit of 8,497 on sale
2024-11-01SELL-20 122.210* 117.52 Profit of 2,350 on sale
2024-11-01SELL-20 122.210* 117.52 Profit of 2,350 on sale
2024-10-31BUY12 120.270* 117.15
2024-10-31BUY12 120.270* 117.15
2024-10-30SELL-76 124.330* 116.05 Profit of 8,820 on sale
2024-10-30SELL-76 124.330* 116.05 Profit of 8,820 on sale
2024-10-29SELL-72 116.190* 116.02 Profit of 8,354 on sale
2024-10-29SELL-72 116.190* 116.02 Profit of 8,354 on sale
2024-10-28BUY6 116.200* 116.01
2024-10-25BUY128 116.080* 115.99
2024-10-25BUY128 116.080* 115.99
2024-10-24BUY16 115.520* 116.14
2024-10-24BUY16 115.520* 116.14
2024-10-23SELL-4 115.080* 116.67 Profit of 467 on sale
2024-10-23SELL-4 115.080* 116.67 Profit of 467 on sale
2024-10-22BUY14 116.780* 116.57
2024-10-22BUY14 116.780* 116.57
2024-10-21SELL-140 116.570* 0.00
2024-10-21SELL-140 116.570* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19138,3040280,71449.3%
2025-09-18207,77644,506326,19463.7%
2025-09-17106,323343194,59754.6%
2025-09-1697,81119,146256,98038.1%
2025-09-1573,3630197,45737.2%
2025-09-1271,8171,305193,96837.0%
2025-09-1187,2040250,36934.8%
2025-09-10117,0990288,60540.6%
2025-09-09123,3791,879226,94154.4%
2025-09-08213,6691,667350,78760.9%
2025-09-05269,8828,988447,93060.3%
2025-09-04193,322481275,12970.3%
2025-09-03210,597108556,90537.8%
2025-09-02183,31915,512318,15057.6%
2025-08-29101,0617,590154,07965.6%
2025-08-28127,383487193,56165.8%
2025-08-27137,4541,818217,03363.3%
2025-08-26170,0223,558291,09658.4%
2025-08-25124,1533,639195,47663.5%
2025-08-22126,62910,885196,28864.5%
2025-08-21119,2451,265200,99059.3%
2025-08-20135,1384,637230,01058.8%
2025-08-19186,010535287,33064.7%
2025-08-18162,0387,351232,60969.7%
2025-08-15140,024100220,19963.6%
2025-08-14290,907253363,13980.1%
2025-08-13356,4048,730466,19176.5%
2025-08-12303,9754,067434,64169.9%
2025-08-11279,1915,617413,02767.6%
2025-08-08338,3850490,22069.0%
2025-08-07341,7192486,06070.3%
2025-08-06162,49452290,74155.9%
2025-08-05127,812122285,40144.8%
2025-08-04184,650798554,60133.3%
2025-08-01384,652274613,13762.7%
2025-07-31795,02721,403,51956.6%
2025-07-30277,359199566,94248.9%
2025-07-29235,4831,232479,50449.1%
2025-07-28128,7961,272304,76342.3%
2025-07-25164,9590533,68230.9%
2025-07-24143,137442360,99139.7%
2025-07-23127,087250336,56737.8%
2025-07-22110,378700199,61455.3%
2025-07-2194,76891171,48155.3%
2025-07-18136,185216238,83657.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.